These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9390547

  • 1. Re: Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat.
    Erren TC, Pinger A, Jacobsen M, Piekarski C.
    J Natl Cancer Inst; 1997 Nov 19; 89(22):1727-8. PubMed ID: 9390547
    [No Abstract] [Full Text] [Related]

  • 2. Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat.
    Komulainen H, Kosma VM, Vaittinen SL, Vartiainen T, Kaliste-Korhonen E, Lötjönen S, Tuominen RK, Tuomisto J.
    J Natl Cancer Inst; 1997 Jun 18; 89(12):848-56. PubMed ID: 9196250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The determination of strong mutagen MX [3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone] in drinking water in China.
    Zou X, Xu X, Zhang J, Zhu Z.
    Chemosphere; 1995 Jun 18; 30(12):2219-25. PubMed ID: 7620850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and mutagenic activity in Massachusetts drinking water.
    Wright JM, Schwartz J, Vartiainen T, Mäki-Paakkanen J, Altshul L, Harrington JJ, Dockery DW.
    Environ Health Perspect; 2002 Feb 18; 110(2):157-64. PubMed ID: 11836144
    [Abstract] [Full Text] [Related]

  • 7. [Chlorination of drinking water--possible cancer risk from a by-product].
    Holme JA, Steffensen IL, Brunborg G, Becher G, Alexander J.
    Tidsskr Nor Laegeforen; 1999 Jun 30; 119(17):2528-30. PubMed ID: 10425909
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Detection of the strong mutagen MX in drinking water].
    Lu J, Zou H, Yu Z, Xu X, Zhang J.
    Huan Jing Ke Xue; 2002 Mar 30; 23(2):123-5. PubMed ID: 12048809
    [Abstract] [Full Text] [Related]

  • 10. Lack of induction of micronuclei in bone marrow erythrocytes of rats exposed to 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) for two years in a carcinogenicity bioassay.
    Jansson K.
    Environ Mol Mutagen; 1998 Mar 30; 32(2):185-7. PubMed ID: 9776182
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the precursors of strong mutagen [3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone]MX by chlorination of fractions from different waters.
    Xu X, Liang L, Zou H, Liu Y, Wang L, Zhang J.
    Chemosphere; 1997 Oct 30; 35(8):1709-16. PubMed ID: 9353905
    [Abstract] [Full Text] [Related]

  • 12. Determination of the strong mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and its analogues by GC-ITD-MS-MS.
    Zwiener C, Kronberg L.
    Fresenius J Anal Chem; 2001 Nov 30; 371(5):591-7. PubMed ID: 11767884
    [Abstract] [Full Text] [Related]

  • 13. Formation of methemoglobin by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone, MX, in rat erythrocytes in vitro.
    Risto L, Vartiainen T, Komulainen H.
    Toxicol Lett; 1993 Jun 30; 68(3):325-32. PubMed ID: 8516786
    [Abstract] [Full Text] [Related]

  • 14. Improved derivatization technique for gas chromatography-mass spectrometry determination of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in drinking water.
    Kubwabo C, Stewart B, Gauthier SA, Gauthier BR.
    Anal Chim Acta; 2009 Sep 07; 649(2):222-9. PubMed ID: 19699398
    [Abstract] [Full Text] [Related]

  • 15. Urine mutagenicity and biochemical effects of the drinking water mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX), following repeated oral administration to mice and rats.
    Meier JR, Monarca S, Patterson KS, Villarini M, Daniel FB, Moretti M, Pasquini R.
    Toxicology; 1996 Jun 17; 110(1-3):59-70. PubMed ID: 8658560
    [Abstract] [Full Text] [Related]

  • 16. Carcinogenicity of the chlorination disinfection by-product MX.
    McDonald TA, Komulainen H.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005 Jun 17; 23(2):163-214. PubMed ID: 16291527
    [Abstract] [Full Text] [Related]

  • 17. Derivatization of the mutagen MX (3-chloro-4(dichloromethyl)-5-hydroxy-2(5H)-furanone) with butyl alcohols prior to GC-MS analysis.
    Nawrocki J, Andrzejewski P, Jeleń H, Wasowicz E.
    Water Res; 2001 Jun 17; 35(8):1891-6. PubMed ID: 11337834
    [Abstract] [Full Text] [Related]

  • 18. Matrix effects in the gas chromatographic-mass spectrometric determination of brominated analogues of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone.
    Rantakokko P, Yritys M, Vartiainen T.
    J Chromatogr A; 2004 Mar 05; 1028(2):179-88. PubMed ID: 14989471
    [Abstract] [Full Text] [Related]

  • 19. Experimental cancer studies of chlorinated by-products.
    Komulainen H.
    Toxicology; 2004 May 20; 198(1-3):239-48. PubMed ID: 15138047
    [Abstract] [Full Text] [Related]

  • 20. Developmental toxicity evaluation of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in Wistar rats.
    Huuskonen H, Venäläinen R, Komulainen H.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Apr 20; 68(2):172-9. PubMed ID: 12866708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.